FDA Rejects Approval Of Corcept’s Relacorilant For Rare Hormonal Disorder, Its Shares Plummeted 48% At $36.41 Jasmine Ara Sayyed January 2, 2026
Novo Nordisk Gets FDA Approval For First-Ever GLP-1 Weight Loss Pill For Oral Obesity Jasmine Ara Sayyed December 23, 2025
